Macitentan;ACT 064992; ACT-064992
| Post Date: |
Jan 23,2013 |
| Expiry Date: |
Jul 22,2013 |
| Detailed Description: |
Cas No. :441798-33-0
Quantity: 1Kilograms
Macitentan is an orally active, non-peptide dual endothelin (ET)(A) and ET(B) receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).
http://www.chemscene.com/Macitentan.html |
| CAS Registry Number: |
|
| Synonyms: |
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide |
| Molecular Formula: |
C19H20Br2N6O4S |
| Molecular Weight: |
588.27 |
| Molecular Structure: |
|
| Company: |
ChemScene, LLC
[ United States ]
|
| Contact: |
Dr. Gao |
| Tel: |
732-484-9848 |
| Fax: |
888-484-5008 |
| Email: |
information@chemscene.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
